rewirebio.iobenchmarks
Evidence claim

Relevance of vep-lit-20261014-protocol-proteingym-clinical-supervised-substitutions-auc-144fe22 to use-case-brca1-brca2-germline-interpretation

Use case
Interpret BRCA1/BRCA2 germline variants
Assessed by
ProteinGym clinical substitutions, supervised predictors, average AUC (commit 144fe22)
Relevance
Proxy evidence
Endpoint
Average over proteins of AUC for supervised clinical predictors (dbNSFP 4.4a), including REVEL and BayesDel

Relevance judgement drafted by the extraction agent; independently reviewed, automated review only.

17 reviewed evaluations

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

57 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance
Citation locations
2 values
  • source id
    vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22
    locator
    Summary_performance_clinical_substitutions_AUC.csv (supervised)
  • source id
    profile-protocol-proteingym-paper-xml-a58110e0
    locator
    ProteinGym NeurIPS 2023 paper (PMC10723403): 'Clinical datasets' (zero-shot and supervised benchmarks), Appendix A.3.2 'Clinical datasets', Appendix 'Limitations' ('Bias', 'Circularity')
Context-only references
Protocol metadata evidence: proteingym-paper.xml

Original source ↗

vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22: Summary_performance_clinical_substitutions_AUC.csv (supervised)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: PMC10723403 retrieved 2026-09-23
Retrieved: 2026-09-23T18:43:10.260678+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: a58110e02c3efc8395c534d48630f577c3d45e90d48198b7f9989cf52600b045

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Citation locations
2 values
  • source id
    vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22
    locator
    Summary_performance_clinical_substitutions_AUC.csv (supervised)
  • source id
    profile-protocol-proteingym-paper-xml-a58110e0
    locator
    ProteinGym NeurIPS 2023 paper (PMC10723403): 'Clinical datasets' (zero-shot and supervised benchmarks), Appendix A.3.2 'Clinical datasets', Appendix 'Limitations' ('Bias', 'Circularity')
Context-only references
OATML-Markslab/ProteinGym / README.md

Original source ↗

vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22: Summary_performance_clinical_substitutions_AUC.csv (supervised)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Git commit 144fe22b07dfaeec2b366f2346203a9838a55b4c
Retrieved: 2026-09-17T09:32:03.517591+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: 321487a8de52c6cfa647a658f61150dd72e0acb0125470524fb94d1f8b23321a

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Citation locations
2 values
  • source id
    vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22
    locator
    Summary_performance_clinical_substitutions_AUC.csv (supervised)
  • source id
    profile-protocol-proteingym-paper-xml-a58110e0
    locator
    ProteinGym NeurIPS 2023 paper (PMC10723403): 'Clinical datasets' (zero-shot and supervised benchmarks), Appendix A.3.2 'Clinical datasets', Appendix 'Limitations' ('Bias', 'Circularity')
Context-only references
ProteinGym clinical supervised substitutions AUC summary at commit 144fe22

Original source ↗

vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22: Summary_performance_clinical_substitutions_AUC.csv (supervised)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 144fe22b07dfaeec2b366f2346203a9838a55b4c
Retrieved: 2026-10-14T13:39:33Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: f2e38aeac2624d87e7a35a5b16bd580de62c24db36973848e1d94ac3ce510359

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison group
proteingym-clinical-144fe22
Context-only references
Protocol metadata evidence: proteingym-paper.xml

Original source ↗

vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22: Summary_performance_clinical_substitutions_AUC.csv (supervised)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: PMC10723403 retrieved 2026-09-23
Retrieved: 2026-09-23T18:43:10.260678+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_group

Source artifact SHA-256: a58110e02c3efc8395c534d48630f577c3d45e90d48198b7f9989cf52600b045

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison group
proteingym-clinical-144fe22
Context-only references
OATML-Markslab/ProteinGym / README.md

Original source ↗

vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22: Summary_performance_clinical_substitutions_AUC.csv (supervised)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Git commit 144fe22b07dfaeec2b366f2346203a9838a55b4c
Retrieved: 2026-09-17T09:32:03.517591+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_group

Source artifact SHA-256: 321487a8de52c6cfa647a658f61150dd72e0acb0125470524fb94d1f8b23321a

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison group
proteingym-clinical-144fe22
Context-only references
ProteinGym clinical supervised substitutions AUC summary at commit 144fe22

Original source ↗

vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22: Summary_performance_clinical_substitutions_AUC.csv (supervised)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 144fe22b07dfaeec2b366f2346203a9838a55b4c
Retrieved: 2026-10-14T13:39:33Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_group

Source artifact SHA-256: f2e38aeac2624d87e7a35a5b16bd580de62c24db36973848e1d94ac3ce510359

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison title
ProteinGym clinical benchmark (commit 144fe22)
Context-only references
Protocol metadata evidence: proteingym-paper.xml

Original source ↗

vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22: Summary_performance_clinical_substitutions_AUC.csv (supervised)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: PMC10723403 retrieved 2026-09-23
Retrieved: 2026-09-23T18:43:10.260678+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_title

Source artifact SHA-256: a58110e02c3efc8395c534d48630f577c3d45e90d48198b7f9989cf52600b045

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison title
ProteinGym clinical benchmark (commit 144fe22)
Context-only references
OATML-Markslab/ProteinGym / README.md

Original source ↗

vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22: Summary_performance_clinical_substitutions_AUC.csv (supervised)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Git commit 144fe22b07dfaeec2b366f2346203a9838a55b4c
Retrieved: 2026-09-17T09:32:03.517591+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_title

Source artifact SHA-256: 321487a8de52c6cfa647a658f61150dd72e0acb0125470524fb94d1f8b23321a

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison title
ProteinGym clinical benchmark (commit 144fe22)
Context-only references
ProteinGym clinical supervised substitutions AUC summary at commit 144fe22

Original source ↗

vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22: Summary_performance_clinical_substitutions_AUC.csv (supervised)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 144fe22b07dfaeec2b366f2346203a9838a55b4c
Retrieved: 2026-10-14T13:39:33Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_title

Source artifact SHA-256: f2e38aeac2624d87e7a35a5b16bd580de62c24db36973848e1d94ac3ce510359

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Constraints
3 values
  • Inspect every linked evaluation's source locator before citing a result.
  • Do not combine this mapping's evaluations with any other protocol's results.
  • Compare rows only within this protocol.
Context-only references
Protocol metadata evidence: proteingym-paper.xml

Original source ↗

vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22: Summary_performance_clinical_substitutions_AUC.csv (supervised)

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: PMC10723403 retrieved 2026-09-23
Retrieved: 2026-09-23T18:43:10.260678+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.constraints

Source artifact SHA-256: a58110e02c3efc8395c534d48630f577c3d45e90d48198b7f9989cf52600b045

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

3 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: use-case-mapping-vep-lit-20261014-brca1-brca2-germline-interpretation-proteingym-clinical-supervised-substitutions-auc-144fe22

field
links:assessed_by:vep-lit-20261014-protocol-proteingym-clinical-supervised-substitutions-auc-144fe22
value
vep-lit-20261014-protocol-proteingym-clinical-supervised-substitutions-auc-144fe22
relevance
proxy
endpoint
Average over proteins of AUC for supervised clinical predictors (dbNSFP 4.4a), including REVEL and BayesDel
rationale
Proxy: covers the predictors most often used for PP3/BP4 (REVEL, BayesDel), pan-gene; not BRCA-specific.
constraints
Inspect every linked evaluation's source locator before citing a result.; Do not combine this mapping's evaluations with any other protocol's results.; Compare rows only within this protocol.
limitations
Performance is reported on all available ClinVar labels, so supervised methods whose training data overlap these labels are likely overestimated; models trained on population frequencies leak further, because most ClinVar benign labels rest on observed frequency (ProteinGym paper, 'Clinical datasets', supervised benchmark).; Clinical labels are biased towards heavily studied proteins, such as well-known cancer genes, and towards European ancestry (ProteinGym paper, Limitations).; Evolutionary conservation is one of the criteria used to classify ClinVar variants, so even zero-shot models are not free of circularity (ProteinGym paper, Limitations).; Per-protein AUC averaged over proteins does not test whether scores are comparable across genes.; The ProteinGym paper describes the 2023 clinical sets; whether the sets behind the 144fe22 files are unchanged is not stated.; Whether BRCA1 or BRCA2 is among the clinical proteins is not stated in the summary files.; Transcribed from the source; no reproduction by Rewire and no human scientific review.
citation locators
source id: vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22; locator: Summary_performance_clinical_substitutions_AUC.csv (supervised); source id: profile-protocol-proteingym-paper-xml-a58110e0; locator: ProteinGym NeurIPS 2023 paper (PMC10723403): 'Clinical datasets' (zero-shot and supervised benchmarks), Appendix A.3.2 'Clinical datasets', Appendix 'Limitations' ('Bias', 'Circularity')
source locator
vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22: Summary_performance_clinical_substitutions_AUC.csv (supervised)
headline metric
auroc
comparison group
proteingym-clinical-144fe22
comparison title
ProteinGym clinical benchmark (commit 144fe22)
stratum label
Substitutions, supervised predictors
stratum order
2
reason
VEP literature pass 2026-10-14: relevance of a newly extracted protocol (rewire-benchmark-data issues #153-#155).
review
reviewer: claude; reviewer note: Claude review agent; no human review claimed. Independent Claude (Opus 5.5) review agent, separate from the extraction agent that built this batch. Automated review only. Transcription, not reproduction.; reviewed at: 2026-10-14T15:30:00Z; method: ai-assisted-source-review; scope-review; method note: Checked the endpoint against the use case's question, inputs, exclusions and setting in data/entities/use-cases.jsonl; checked each limitation against the cited sources; listed every evaluation on the protocol in reviewed_evaluations after review/check_values.py matched its results.; note: Judgement drafted by the extraction agent and revised in review (docs/reviews/vep-literature-2026-10-14-review.md). Proxy is justified; see the dated review.
reviewed evaluations
vep-lit-20261014-eval-pg-css-proteingym-clinical-bayesdel-addaf; vep-lit-20261014-eval-pg-css-proteingym-clinical-bayesdel-noaf; vep-lit-20261014-eval-pg-css-proteingym-clinical-cadd; vep-lit-20261014-eval-pg-css-proteingym-clinical-clinpred; vep-lit-20261014-eval-pg-css-proteingym-clinical-dann; vep-lit-20261014-eval-pg-css-proteingym-clinical-deogen2; vep-lit-20261014-eval-pg-css-proteingym-clinical-fathmm; vep-lit-20261014-eval-pg-css-proteingym-clinical-gmvp; vep-lit-20261014-eval-pg-css-proteingym-clinical-metarnn; vep-lit-20261014-eval-pg-css-proteingym-clinical-mpc; vep-lit-20261014-eval-pg-css-proteingym-clinical-mutationtaster; vep-lit-20261014-eval-pg-css-proteingym-clinical-polyphen2-hdiv; vep-lit-20261014-eval-pg-css-proteingym-clinical-polyphen2-hvar; vep-lit-20261014-eval-pg-css-proteingym-clinical-revel; vep-lit-20261014-eval-pg-css-proteingym-clinical-varity-er; vep-lit-20261014-eval-pg-css-proteingym-clinical-varity-r; vep-lit-20261014-eval-pg-css-proteingym-clinical-vest4
pins
record id: profile-protocol-proteingym-paper-xml-a58110e0; fields: status; attributes.artifact_sha256; sha256: 55a285515bd12e2145721382fccb111bba8ae70f3dd4e1c5aeae2afdc0c00e0d; record id: run-doc-proteingym-readme-md-144fe22b; fields: status; attributes.artifact_sha256; sha256: 70823ddfc9ef5ced58ba8aea340a8d99cf7808ee58b0d2cd4ee1abe5f6684646; record id: use-case-brca1-brca2-germline-interpretation; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 9681ae92e727dde7a801aec8d4884ec28b009d134a52d806a266f7d3b64bd5bd; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-bayesdel-addaf; fields: status; links; attributes.origin; attributes.comparison; sha256: 6c924d3a7c112c6b4f2becb9be942c8d74765e223a607bd930b24f62240e6bbf; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-bayesdel-noaf; fields: status; links; attributes.origin; attributes.comparison; sha256: 7070b1c78a1ad77c29e6ebdbfe0f1c4153d4027d625830a78f22bbb2ae5c8729; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-cadd; fields: status; links; attributes.origin; attributes.comparison; sha256: 4da57aca7b85f7a9311d0b1e09ae27bd41bcfdf1a1898b850dfb3bd7c18fb557; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-clinpred; fields: status; links; attributes.origin; attributes.comparison; sha256: 262c32bb50554e6fe8f790b64a5edb927ed98e68269a1118119ac359e6937097; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-dann; fields: status; links; attributes.origin; attributes.comparison; sha256: 038c8e440d91d54b166a141ab94287e7d93593e19dd2f8192daaaa8f36173007; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-deogen2; fields: status; links; attributes.origin; attributes.comparison; sha256: 8f947e2f7e527250429177530207d68e0153a7bb5c154c3a7b755d64ef36ff53; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-fathmm; fields: status; links; attributes.origin; attributes.comparison; sha256: 0bee92945eb58a8445a90a4524031f87d05a281d688ac7d185a8682e2d777b6b; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-gmvp; fields: status; links; attributes.origin; attributes.comparison; sha256: df7e6911d56cfcadc952cceec4f19d39b54ff2200a3f3953ad9ba617b9173403; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-metarnn; fields: status; links; attributes.origin; attributes.comparison; sha256: 101cd6bce3310e280d756c297f39e498cad2a407b7b2435811d2b7ab95ab936e; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-mpc; fields: status; links; attributes.origin; attributes.comparison; sha256: 59ceffe04073817e19bfc7717d70e97b1b34cdf87dae0155b5f70b4f5af57430; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-mutationtaster; fields: status; links; attributes.origin; attributes.comparison; sha256: 76cfda7e2dc71c82c4f1d42a8e4a8c8cc24a55cfa3f1164c2443213e147b81ad; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-polyphen2-hdiv; fields: status; links; attributes.origin; attributes.comparison; sha256: 2ade03c922440ffccf415805d828009d4c1cff65fa0ab3775b056bf20f9a927b; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-polyphen2-hvar; fields: status; links; attributes.origin; attributes.comparison; sha256: 1e45f4a2621d2e2304fa9e478423c95d4a586eefe8ab6fc0af3f8de8c7a392d4; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-revel; fields: status; links; attributes.origin; attributes.comparison; sha256: 4e1ad2973e53cb7fc12092888661ff223eb3da7dd1ad1c99157060a6ef9a79f2; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-varity-er; fields: status; links; attributes.origin; attributes.comparison; sha256: 800e1677b31bae5e923088846179fd34a6a4f83b3d389513ce60fb5f6a2b19ce; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-varity-r; fields: status; links; attributes.origin; attributes.comparison; sha256: a65750a5c7a6d3c0adb664c6e90c89ac401dcfffa20da6a2f01c85a7d583ef08; record id: vep-lit-20261014-eval-pg-css-proteingym-clinical-vest4; fields: status; links; attributes.origin; attributes.comparison; sha256: dd3829f8ec1125f1319bf09d11fc212f5f29b96d5cc4da1ba8e46024d53b126b; record id: vep-lit-20261014-protocol-proteingym-clinical-supervised-substitutions-auc-144fe22; fields: status; name; description; facets; source_ids; links; attributes; sha256: 718c15cdbd4989f6033334b65319a6ef5dc8174489ca666e15c0d617b1a71d95; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-bayesdel-addaf-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 31f46b207e03fb624b8f041370a9cdef88be6444db746a61e5488efb54faa2d5; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-bayesdel-noaf-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 1e1d21ca91107afb01baa97bcbc72340fa570a9bdab0a3f66679427ce250ff42; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-cadd-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: cc86137192da5fa5e82e28e5ebe9cbf82a4c0a793f262ca4eb0d1f29688a421a; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-clinpred-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: c06d0b3e3e22b9b14f52da6e0939887f54828a74aca4636293fb8562cd3c75f2; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-dann-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d3392a36dc37cf66cd550f062ce6714335ff05e6bfe05772d7949b7cbf92652b; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-deogen2-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: ea4f27cf29736926ded11a169ddfda181c0f917c7edf45f9971fc526df1b118b; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-fathmm-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: bef626c25a8a02edd8ee805e1d65275e0383ab824a4565a7ac240f983529f960; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-gmvp-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 8edac6c9fd0c985924411d4b48946c0decb12444f91097c794b857813adfd5a5; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-metarnn-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 9df7769c6e26d5b183945eb7d4663e5518d4a0e1919ff64f9099a7b9d571f7ef; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-mpc-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 9c40419816791656f6e8e33dfdce2a512809e8de68c661b14e7a8fae12aced57; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-mutationtaster-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 804d86de2fd3837588b63678a3b996697ce8812026beff519b98d4ee18301963; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-polyphen2-hdiv-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 00ce21bca775bbd3eda25c861404d9ee2ad32b7fc3a877445480c6668e1ab7e9; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-polyphen2-hvar-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 6a6926e19851c96e0528c18590fd0ecda297fc3840edc25836311ca422ada0e4; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-revel-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d877a8c8f1da08fa842da13a6af62a615951bf5a3c8c7acf027429dce58ed62c; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-varity-er-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: efc539ec0fa1e3419132a2059998c972882e7145a84c2673ed1ff62e2b17e2b1; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-varity-r-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 7cd9eb94bc91d393b5d2ba6eb53cf7afab27f4c4eb278370a151a919a6efb40d; record id: vep-lit-20261014-result-pg-css-proteingym-clinical-vest4-average-auc; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: eb11621dccd37c77511a22466033f3d173e64e65d4bf8f55ae071e975190d8ec; record id: vep-lit-20261014-source-proteingym-clinical-supervised-substitutions-auc-summary-144fe22; fields: status; attributes.artifact_sha256; sha256: a3b280aaeea6c608c1e79070e378c56f3f4480c88bf6ca5a568e93dea09c4c4b
Related records

Suggest a correction